Neurocrine Bioscience buy Citigroup Inc.
Start price
29.10.25
/
50%
€117.75
Target price
29.10.26
€174.28
Performance (%)
-0.51%
Price
22:26
€117.15
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by -0.51%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 4.005% | 4.005% |
| iShares Core DAX® | 1.085% | -1.655% |
| iShares Nasdaq 100 | -1.665% | -3.137% |
| iShares Nikkei 225® | 3.863% | 6.947% |
| iShares S&P 500 | 0.111% | -1.320% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat